Cooperation between Prokaryotic (Lde) and Eukaryotic (MRP) Efflux Transporters in J774 Macrophages Infected withListeria monocytogenes: Studies with Ciprofloxacin and Moxifloxacin
Open Access
- 1 September 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (9), 3040-3046
- https://doi.org/10.1128/aac.00105-08
Abstract
Antibiotic efflux is observed in both eukaryotic and prokaryotic cells, modulating accumulation and resistance. The present study examines whether eukaryotic and prokaryotic fluoroquinolone transporters can cooperate in the context of an intracellular infection. We have used (i) J774 macrophages (comparing a ciprofloxacin-resistant cell line overexpressing an MRP-like transporter with wild-type cells with basal expression), (ii)Listeria monocytogenes(comparing a clinical isolate [CLIP21369] displaying ciprofloxacin resistance associated with overexpression of the Lde efflux system with a wild-type strain [EGD]), (iii) ciprofloxacin (substrate of both Lde and MRP) and moxifloxacin (nonsubstrate), and (iv) probenecid and reserpine (preferential inhibitors of MRP and Lde, respectively). The ciprofloxacin MICs for EGD were unaffected by reserpine, while those for CLIP21369 were decreased approximately fourfold (and made similar to those of EGD). Neither probenecid nor reserpine affected the moxifloxacin MICs against EGD or CLIP21369. In dose-response studies (0.01× to 100× MIC) in broth, reserpine fully restored the susceptibility of CLIP21369 to ciprofloxacin (no effect on EGD) but did not influence the activity of moxifloxacin. In studies with intracellular bacteria, reserpine, probenecid, and their combination increased the activity of ciprofloxacin in wild-type and ciprofloxacin-resistant macrophages in parallel with an increase in ciprofloxacin accumulation in macrophages for EGD and an increase in accumulation and decrease in MIC (in broth) for CLIP21369. Moxifloxacin accumulation and intracellular activity were consistently not affected by the inhibitors. A bacterial efflux pump may thus actively cooperate with a eukaryotic efflux transporter to reduce the activity of a common substrate (ciprofloxacin) toward an intracellular bacterial target.Keywords
This publication has 39 references indexed in Scilit:
- Comparison of the In Vitro Efficacies of Moxifloxacin and Amoxicillin against Listeria monocytogenesAntimicrobial Agents and Chemotherapy, 2008
- Modulation of the Cellular Accumulation and Intracellular Activity of Daptomycin towards Phagocytized Staphylococcus aureus by the P-Glycoprotein (MDR1) Efflux Transporter in Human THP-1 Macrophages and Madin-Darby Canine Kidney CellsAntimicrobial Agents and Chemotherapy, 2007
- Contribution of Penicillin-Binding Protein Homologs to Antibiotic Resistance, Cell Morphology, and Virulence of Listeria monocytogenes EGDeAntimicrobial Agents and Chemotherapy, 2006
- Cellular Accumulation and Activity of Quinolones in Ciprofloxacin-Resistant J774 MacrophagesAntimicrobial Agents and Chemotherapy, 2006
- Development and validation of an HPLC method for the determination of gatifloxacin stability in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2006
- Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)FEBS Letters, 2005
- Azithromycin, a Lysosomotropic Antibiotic, Has Distinct Effects on Fluid-Phase and Receptor-Mediated Endocytosis, but Does Not Impair Phagocytosis in J774 MacrophagesExperimental Cell Research, 2002
- Interaction of Cytochrome P450 3A Inhibitors with P-GlycoproteinJournal of Pharmacology and Experimental Therapeutics, 2002
- Active Transport of Fluorescent P-Glycoprotein Substrates: Evaluation as Markers and Interaction with InhibitorsBiochemical and Biophysical Research Communications, 2001
- Clinical Pharmacokinetics of ProbenecidClinical Pharmacokinetics, 1981